Patent application number | Description | Published |
20100205567 | ADAPTIVE UI REGIONS FOR ENTERPRISE APPLICATIONS - An adaptive region system can include an adaptive region module and a display module. The adaptive region module can include a mini region button panel module capable of generating a mini region button panel having multiple mini region buttons, a view panel module capable of generating a view panel having multiple view buttons, and a region panel module capable of generating a region panel having multiple mini regions. The display module can visually display the mini region button panel, the view panel, and the region panel. | 08-12-2010 |
20120036462 | MECHANISM TO COMMUNICATE AND VISUALIZE DEPENDENCIES BETWEEN A LARGE NUMBER OF FLOWS IN SOFTWARE - In various embodiments, techniques for communicating and visualizing dependencies between a large number of flows are provided. One or more user interfaces can be generated that enable users to interact with information needed to complete each tasks in an ordered or unordered listing of tasks. In some aspects, elements of these user interfaces can including functionality enabling users to interact with each tasks, navigate to information needed to complete each task. In another aspect, one or more styles of presenting information is provided that facilitates navigation to dependency information for each task in a more useful manner. In further aspects, elements of these user interfaces can visually communicate the above functionality and dependency information as well as additional information about each tasks, such as status information, ownership information, or providing an audit trail. | 02-09-2012 |
20130074063 | MANAGING DATA LINKED WITH THE SETUP, INSTALLATION, AND CONFIGURATION OF ENTERPRISE SOFTWARE - Various arrangements for installing, setting up, and configuring enterprise software are presented. A set of business characteristics may be received in response to a questionnaire. The set of business characteristics may be analyzed in conjunction with various tasks of one task lists, wherein each task comprises one or more data gathering setup steps for enterprise software. Using the business characteristics, various tasks may be identified as requiring or not requiring user input because of the applicability to the customer. A task list that indicates tasks needing to be completed may be presented to the user. | 03-21-2013 |
20140089822 | TASK-CENTERED CONTEXT MANAGEMENT - A method, system, and computer program product for interaction management systems. The method commences upon receiving a first incoming communication pertaining to a first task, and launching a first task-centered context user interface being initially populated with a first screen device selected in response to the type of incoming communication (e.g., a phone call icon, etc.). An agent interacts with the client by responding to the incoming communication. Then, the method receives a second incoming communication pertaining to the same first task; and populates the first task-centered context user interface with a second screen device appropriate for the second incoming communication (e.g., a chat UI, etc.). Additional new incoming events are routed to its corresponding task-centered context (or a new task-centered context is created). Thus, upon receiving a third incoming communication pertaining to a second task (different from the first task), the method launches a second task-centered context user interface. | 03-27-2014 |
20140101261 | METHOD AND SYSTEM FOR COMMUNICATING WITHIN A MESSAGING ARCHITECTURE USING A STRUCTURED DATA OBJECT - A method, system, and computer-program product for communicating within a messaging architecture using a structured data object are disclosed. The method includes identifying a structured data object configured to represent structured data, receiving the structured data at a messaging system, generating a message that includes the structured data, and sending the message. The structured data object is configured to be accessed by an application and the messaging system, and includes a request element and a response element. The sending includes transferring the message via the messaging system. | 04-10-2014 |
20140101262 | METHOD AND SYSTEM FOR COMMUNICATING WITHIN A MESSAGING ARCHITECTURE USING DYNAMIC FORM GENERATION - A method, system, and computer-program product for communicating within a messaging architecture using a structured data object are disclosed. The method includes assembling a dynamic form object and submitting dynamic form information, associated with the dynamic form object, into a messaging session. The assembling includes an assembly operation, which, in turn, includes identifying an input field of an interface of an application, transferring input field information to a messaging system, and generating an element of the dynamic form object. The input field information is associated with the input field, and the generating uses the input field information. Further, the submitting includes transferring a message via the messaging system, the message including the dynamic form information. | 04-10-2014 |
20140101263 | MESSAGING ARCHITECTURE CONFIGURED TO USE AN EXECUTION-ENABLED ELEMENT TO INITIATE AN OPERATION IN AN APPLICATION - A method, system, and computer-program product for communicating within a messaging architecture using a structured data object are disclosed. The method includes receiving an execution-enabled object and receiving a selection of the execution-enabled element. Such an execution-enabled object is configured to be included in a message sent by a messaging system. The execution-enabled object includes a response element and an execution-enabled element. The response element and the execution-enabled element are associated with one another. The execution-enabled element is configured to post an event to the messaging system upon the execution-enabled element being activated. The selection of the execution-enabled element activates the execution-enabled element. | 04-10-2014 |
20140123072 | SYSTEM FOR NAVIGATION IN A COMPUTER USER INTERFACE - Embodiments described herein provide various features for a unified and simplified user experience. A first feature (or set of features) provides icons for launching or accessing applications and business flows. A second feature provides a unified menu system including an icon bar with thumbnails of a selected icon arranged adjacent to the icon bar. A third feature provides a framework for a menu that can expose application objects from diverse sources. | 05-01-2014 |
20140282213 | MANAGEMENT OF MULTIPLE SYNCHRONIZED WINDOWS - A system and method for facilitating user interaction with a software application. An example method includes displaying a first primary window of an application; providing a user option to select a sub-window of the first primary window, resulting in generation of a detached window corresponding to the sub-window in response thereto; leaving a first user interface control in the first primary window in place of the sub-window, wherein the first user interface control provides a first user option to implement a first action pertaining to the detached window; and including a second user interface control in proximity to the detached window, wherein the second user interface control provides a first user option to implement a second action applicable to the detached window and primary window. The user interface controls may be implemented via headers in the primary window and detached window. Data is automatically synchronized between windows. | 09-18-2014 |
20140282217 | WINDOW GROUPING AND MANAGEMENT ACROSS APPLICATIONS AND DEVICES - A system and method for facilitating user access to data and software functionality. An example method includes identifying open windows of plural software applications; accessing rules pertaining to one or more behaviors of one or more of the open windows; and using the rules to adjust the one or more behaviors in accordance with a context of each of the open windows. In a more specific embodiment, the one or more behaviors are adjusted via window groupings in accordance with window context, which includes one or more keywords associated with open windows. The example method further includes displaying a search window with a user option to enter a query using keywords. Search results may identify documents that are associated with window groups associated with keywords of the query. | 09-18-2014 |
20150074541 | DESKTOP AND MOBILE DEVICE INTEGRATION - A system and method for facilitating user interface interactions between different computing devices. An example method includes providing a first user option to select a first portion of a first user interface display screen presented on a first computing device; providing a signal based on the selected portion; and using the signal to display one or more items in a second user interface display screen via a second computing device based on the first portion and one or more mapping rules. In a more specific embodiment, the example method further includes providing a second user option to adjust the mapping rules. The first portion includes, for example, a table row or column. The one or more items displayed via the second computing device include, for example, a visualization based on data associated with the first portion. | 03-12-2015 |
20150074763 | PROXIMITY AND BEHAVIOR-BASED ENTERPRISE SECURITY USING A MOBILE DEVICE - A system and method for facilitating configuring software security functionality. An example method includes employing a first computing device to collect information associated with a user of enterprise software, resulting in collected information; and dynamically adjusting one or more security features of enterprise software running on or accessible via a second device based on the collected information. The software running on the second device may include or represent the enterprise software that includes software security functionality. The collected information may include contextual information. An administrator user option facilitates adjusting the one or more rules. | 03-12-2015 |
Patent application number | Description | Published |
20140045193 | METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION - The invention relates to the use of enzymes and nanorods to detect cysteine level in a patient sample and relates to the use of the detected cysteine level to predict cancer recurrence in the patient. The invention is directed to systems and methods of detecting cysteine level in a sample from a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention is directed to systems and methods of predicting the probability of a recurrence of a cancer in a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. This invention is directed to systems and methods of predicting the probability of a recurrence of a cancer in a subject and treating the subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. | 02-13-2014 |
20150204882 | METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION - The invention relates to the use of enzymes, nanorods, and nanoelectronic devices to detect cysteine level in a patient sample and relates to the use of the detected cysteine level to predict cancer recurrence in the patient and to prescribe and/or administer an appropriate therapy to a subject. The invention is directed to systems and methods of detecting cysteine level in a sample from a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention is directed to systems and methods of predicting the probability of a recurrence of a cancer in a subject, wherein the systems or methods can further comprise measuring at least one additional parameter, such as PSA level, Gleason score and clinical stage. The invention further comprises prescribing and/or administering an appropriate therapy to a subject based on the predicted probability of recurrence. | 07-23-2015 |
Patent application number | Description | Published |
20140351184 | USER SPECIFIC PLAN GENERATION METHOD AND SYSTEM - The present invention envisages a personalized plan generation system and a method that satisfies maximum user preferences and constraints; besides including a number of enabling features like of plan repair or revision with dynamically changing situations or contextual information. Moreover, the system is able to perform a collaborative planning by opinion mining in social networks to achieve better optimization. Significantly, the explanation for the selection of plan steps or a change in plan altogether can be expressed in natural language. | 11-27-2014 |
20140351790 | INTERNET OF THINGS (IOT) APPLICATION DEVELOPMENT - An application development system for development of Internet of Things (IoT) application includes a cataloging module to obtain an input from an application developer. The input comprises data related to the IoT application to be developed. The cataloging module further retrieves a plurality of reusable artefacts from a knowledge database based on the input. A recommendation module in the application development system recommends, to the application developer, artefacts from amongst the plurality of reusable artefacts, based at least on one of a feedback associated with each of the plurality of reusable artefacts, an expert analysis, and a combination of the expert analysis and the feedback. An association module in the application development system associates artefacts selected by the application developer with each other for development of the IoT application. | 11-27-2014 |
20150067690 | SYSTEM AND METHOD FOR GENERATING A PLAN TO COMPLETE A TASK IN COMPUTING ENVIRONMENT - A system and method for generating a plan to complete a task by providing a framework facilitating use of heterogeneous data sources without altering a planning algorithm are disclosed. The method includes using a first dataset of logical atoms represented in predicate schema and second dataset of database atoms represented in non-predicate schema, and modifying a grammar rule, a domain definition, and a problem definition, and selecting and executing task methods and task operators to complete a task. Execution of task operator includes verifying a precondition, assigning variables with values when the precondition is valid, and modifying (delete and add) a plan state. Execution of the task method includes verifying a precondition of the task method, assigning variables with values when the precondition is valid, decomposing the task into sub-tasks, assigning arguments of task method to sub-tasks, and adding sub-tasks to a task list. Thereafter, a plan is generated. | 03-05-2015 |
Patent application number | Description | Published |
20130288968 | LEUPROLIDE INJECTION - The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile. | 10-31-2013 |
20130303453 | OCTREOTIDE INJECTION - The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution, while the reservoir remains sterile. | 11-14-2013 |
20140155835 | LEUPROLIDE INJECTION - The present invention provides a sterile solution comprising leuprolide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in a single daily dose and further being adapted to provide multiple portions of solution said while the reservoir remains sterile. | 06-05-2014 |
20140213984 | OCTREOTIDE INJECTION - The present invention provides a sterile solution comprising octreotide acetate in a pharmaceutically acceptable vehicle, wherein solution is present as a reservoir in a multiple dose pen injection device, the device being adapted to subcutaneously inject a portion of the said reservoir in multiple daily doses and further being adapted to provide multiple portions of the said solution, while the reservoir remains sterile. | 07-31-2014 |
Patent application number | Description | Published |
20080262078 | Pharmaceutical Compositions - The present invention relates to a process for the preparation of a stable lyophilized form of a water insoluble drug suitable for parenteral use and pharmaceutical compositions comprising such lyophilized form of the drug. | 10-23-2008 |
20090104274 | PROCESS OF MAKING MICROSPHERES - A process for the manufacture of free-flowing uniformly sized micro spheres for the sustained release of therapeutically active ingredient comprising: a) preparing a first dispersed phase comprising a therapeutically active ingredient, a biodegradable polymer and an organic solvent; b) mixing the first dispersed phase with a aqueous phase to form an emulsion; c) spraying the emulsion into a vessel ( | 04-23-2009 |
20090110744 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS - A sustained release microsphere composition comprising—
| 04-30-2009 |
20090123556 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS - The present invention provides a sustained release microsphere composition comprising | 05-14-2009 |
20100137432 | OPHTHALMIC COMPOSITION COMPRISING A PROSTAGLANDIN - The present invention relates to a pharmaceutical composition suitable for ophthalmic use comprising one or more prostaglandin derivatives or salts, a stabilizing amount of polyethylene glycol hydroxystearate and pharmaceutically acceptable vehicle. | 06-03-2010 |
20100163042 | INHALATION DEVICE - The present invention relates to an inhalation-activatable device for administration of medicament in powder form to the respiratory system of a patient. | 07-01-2010 |
20100297244 | NANODISPERSION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more taxane derivative, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 11-25-2010 |
20110166101 | MICROPARTICLES - A substantially porous, micro-particle comprising therapeutically effective amounts of tretinoin and ethyl cellulose | 07-07-2011 |
20110275597 | PHARMACEUTICAL COMPOSITION - The present invention relates to a parenteral pharmaceutical composition comprising therapeutically effective amounts of N-(2-pyrazine)carbonyl-L-phenylalanine-L-leucine boronic acid or its salts or its derivatives and tromethamine wherein the composition is stable. | 11-10-2011 |
20120087959 | NANODISPERSION OF A DRUG AND PROCESS FOR ITS PREPARATION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more drugs, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 04-12-2012 |
20130267591 | NOVEL OPHTHALMIC COMPOSITIONS - An ophthalmic solution comprising therapeutically effective amount of a prostaglandin or its analog and water soluble excipient(s) dissolved in a pharmaceutically acceptable vehicle, wherein the solution is free of a surfactant. | 10-10-2013 |
20140030352 | NANODISPERSION - The present invention provides a nanodispersion comprising nanoparticles having a mean size less than 300 nm dispersed in a vehicle comprising a water miscible solvent and water, said nanoparticles comprising one or more taxane derivative, a polymer and a surfactant comprising a mixture of fatty acids or its salts and sterol or its derivatives or its salts. | 01-30-2014 |
20150290216 | OPHTHALMIC COMPOSITION COMPRISING A PROSTAGLANDIN - The present invention relates to a pharmaceutical composition suitable for ophthalmic use comprising one or more prostaglandin derivatives or salts, a stabilizing amount of polyethylene glycol hydroxystearate and pharmaceutically acceptable vehicle. | 10-15-2015 |
20150290277 | PHARMACEUTICAL COMPOSITION - The present invention relates to a parenteral pharmaceutical composition comprising therapeutically effective amounts of N-(2-pyrazine) carbonyl-L-phenylalanine-L-leucine boronic acid or its salts or its derivatives and tromethamine wherein the composition is stable. | 10-15-2015 |
20160081972 | PARENTERAL DOSAGE FORM OF AMIODARONE - The present invention relates to a stable, sterile, ready to administer parenteral dosage form of amiodarone or its pharmaceutically acceptable salt. Particularly, the present invention provides a stable, sterile, ready to administer parenteral dosage form of amiodarone comprising an aqueous solution comprising amiodarone or its pharmaceutically acceptable salt, an acid, and a polyol, wherein the pH of the solution is in the range of about 2.0 to 4.0, wherein the solution is filled in a plastic container and wherein the solution is free of a solubilizer. | 03-24-2016 |